Casey Cunningham, M.D.
Casey joined Santé Ventures in 2008. As Chief Scientific Officer, he performs scientific and technical assessments for current and potential portfolio companies. Casey has also served as Chief Medical Officer for three Santé Ventures portfolio companies: Terapio, Molecular Templates and Beta Cat Pharmaceuticals.
Prior to Santé, Casey was Associate Director of the Mary Crowley Cancer Research Center where he was the principal investigator on numerous trials, with emphasis on gene and cell-based therapies.
Casey attended fellowship training in oncology and hematology at the Harvard Medical School, where he subsequently served on the faculty. He is also a founding member of the Division of Experimental Medicine at the Brigham & Women’s Hospital, where he established a Cell and Molecular Biology research laboratory.
Casey earned his MD from the University of Texas Southwestern Medical School, with an internal medicine residency at the Medical College of Wisconsin. He earned his BS in physics and biology from Texas A&M.